These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25620169)

  • 1. Interleukin-33 promotes the proliferation of mouse mast cells through ST2/MyD88 and p38 MAPK-dependent and Kit-independent pathways.
    Saluja R; Hawro T; Eberle J; Church MK; Maurer M
    J Biol Regul Homeost Agents; 2014; 28(4):575-85. PubMed ID: 25620169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals.
    Ho LH; Ohno T; Oboki K; Kajiwara N; Suto H; Iikura M; Okayama Y; Akira S; Saito H; Galli SJ; Nakae S
    J Leukoc Biol; 2007 Dec; 82(6):1481-90. PubMed ID: 17881510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-33-activated dendritic cells induce the production of thymus and activation-regulated chemokine and macrophage-derived chemokine.
    Kurokawa M; Matsukura S; Kawaguchi M; Ieki K; Suzuki S; Watanabe S; Homma T; Yamaguchi M; Takeuchi H; Adachi M
    Int Arch Allergy Immunol; 2013; 161 Suppl 2():52-7. PubMed ID: 23711854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α Regulates Mast Cell Functions by Inhibiting Cell Degranulation.
    Gao Y; Xu B; Zhang P; He Y; Liang X; Liu J; Li J
    Cell Physiol Biochem; 2017; 44(2):751-762. PubMed ID: 29169157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons.
    He Z; Song J; Hua J; Yang M; Ma Y; Yu T; Feng J; Liu B; Wang X; Li Y; Li J
    Cell Death Dis; 2018 Dec; 9(12):1173. PubMed ID: 30518915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-33 primes mast cells for activation by IgG immune complexes.
    Kaieda S; Wang JX; Shnayder R; Fishgal N; Hei H; Lee RT; Stevens RL; Nigrovic PA
    PLoS One; 2012; 7(10):e47252. PubMed ID: 23071771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation.
    Shik D; Moshkovits I; Karo-Atar D; Reichman H; Munitz A
    Allergy; 2014 Jun; 69(6):719-29. PubMed ID: 24735452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.
    Moulin D; Donzé O; Talabot-Ayer D; Mézin F; Palmer G; Gabay C
    Cytokine; 2007 Dec; 40(3):216-25. PubMed ID: 18023358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
    Palmer G; Lipsky BP; Smithgall MD; Meininger D; Siu S; Talabot-Ayer D; Gabay C; Smith DE
    Cytokine; 2008 Jun; 42(3):358-64. PubMed ID: 18450470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophin-3 regulates mast cell functions in neonatal mouse skin.
    Metz M; Botchkarev VA; Botchkareva NV; Welker P; Tobin DJ; Knop J; Maurer M; Paus R
    Exp Dermatol; 2004 May; 13(5):273-81. PubMed ID: 15140017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33/ST2 axis promotes mast cell survival via BCLXL.
    Wang JX; Kaieda S; Ameri S; Fishgal N; Dwyer D; Dellinger A; Kepley CL; Gurish MF; Nigrovic PA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10281-6. PubMed ID: 24982172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 induces a hyporesponsive phenotype in human and mouse mast cells.
    Jung MY; Smrž D; Desai A; Bandara G; Ito T; Iwaki S; Kang JH; Andrade MV; Hilderbrand SC; Brown JM; Beaven MA; Metcalfe DD; Gilfillan AM
    J Immunol; 2013 Jan; 190(2):531-8. PubMed ID: 23248261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-33 causes selective mast cell tolerance to bacterial cell wall products by inducing IRAK1 degradation.
    Sandig H; Jobbings CE; Roldan NG; Whittingham-Dowd JK; Orinska Z; Takeuchi O; Akira S; Bulfone-Paus S
    Eur J Immunol; 2013 Apr; 43(4):979-88. PubMed ID: 23404570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent.
    Enoksson M; Möller-Westerberg C; Wicher G; Fallon PG; Forsberg-Nilsson K; Lunderius-Andersson C; Nilsson G
    Blood; 2013 Jan; 121(3):530-6. PubMed ID: 23093619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice.
    Ouziel R; Gustot T; Moreno C; Arvanitakis M; Degré D; Trépo E; Quertinmont E; Vercruysse V; Demetter P; Le Moine O; McKenzie AN; Delhaye M; Devière J; Lemmers A
    Am J Pathol; 2012 Jun; 180(6):2330-9. PubMed ID: 22542450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.
    Bandara G; Beaven MA; Olivera A; Gilfillan AM; Metcalfe DD
    Eur J Immunol; 2015 Nov; 45(11):3034-44. PubMed ID: 26256265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-33 exacerbates autoantibody-induced arthritis.
    Xu D; Jiang HR; Li Y; Pushparaj PN; Kurowska-Stolarska M; Leung BP; Mu R; Tay HK; McKenzie AN; McInnes IB; Melendez AJ; Liew FY
    J Immunol; 2010 Mar; 184(5):2620-6. PubMed ID: 20139274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.
    Drube S; Heink S; Walter S; Löhn T; Grusser M; Gerbaulet A; Berod L; Schons J; Dudeck A; Freitag J; Grotha S; Reich D; Rudeschko O; Norgauer J; Hartmann K; Roers A; Kamradt T
    Blood; 2010 May; 115(19):3899-906. PubMed ID: 20200353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-33 synergistically enhances immune complex-induced tumor necrosis factor alpha and interleukin-8 production in cultured human synovium-derived mast cells.
    Kashiwakura J; Yanagisawa M; Lee H; Okamura Y; Sasaki-Sakamoto T; Saito S; Tokuhashi Y; Ra C; Okayama Y
    Int Arch Allergy Immunol; 2013; 161 Suppl 2():32-6. PubMed ID: 23711851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice.
    Wu H; Yang S; Wu X; Zhao J; Zhao J; Ning Q; Xu Y; Xie J
    Biochem Biophys Res Commun; 2014 Jul; 450(1):110-6. PubMed ID: 24866242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.